RHE, sirtuin 1 expression (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Sirtuin 1 immunolabeling |
| EPIBA-0012 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | Sirtuin 1 immunolabeling | Immunohistofluorescence | Basal | |
RHE, mitochondrial dehydrogenase activity (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | MTT reduction |
| EPIBA-0016 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | MTT reduction | Photometry | Basal | |
RHE, ATP content (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | ATP |
| EPIBA-0017 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | ATP | Luminescence | Basal | |
RHE, glucose consumption (basal)| Type of assay | Metabolism | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Glucose quantification (kinetics) |
| EPIBA-0056 | Keratinocyte viability & metabolism | Metabolism | Reconstructed Epidermis, BIOalternatives RHE | Human | Glucose quantification (kinetics) | Photometry | Basal | |
NHEK, malate dehydrogenase activity| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | MDH activity |
| NHEK-0004 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | MDH activity | Photometry | Basal | |
NHEK, glucose consumption (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | Glucose quantification (kinetics) |
| NHEK-0044 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | Glucose quantification (kinetics) | Photometry | Basal | |
NHEK, mitochondrial dehydrogenase activity (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | MTT reduction |
| NHEK-0049 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | MTT reduction | Photometry | Basal | |
NHEK, ATP content (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | ATP |
| NHEK-0051 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | ATP | Luminescence | Basal | |
NHEK, creatine kinase activity (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | Creatine kinase activity |
| NHEK-0052 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | Creatine kinase activity | Photometry | Basal | |
NHEK, mTOR activation pathway (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | rpS6 phosphorylation |
| NHEK-0077 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | rpS6 phosphorylation | Fluorescence / imaging | Basal | |
NHEK, AMPK activation (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | AMPK phosphorylation |
| NHEK-0082 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | AMPK phosphorylation | Western blot | Basal | |
NHEK, mTOR inhibition pathway (EGF+PE stimulation)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | rpS6 phosphorylation |
| NHEK-0092 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | rpS6 phosphorylation | Fluorescence / imaging | EGF / PE | |
NHEK, vitamin C uptake (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | Vitamin C uptake |
| NHEK-0118 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | Vitamin C uptake | [14C]-ascorbic acid incorporation | Basal | |
NHEK, vitamin C transport (basal)| Type of assay | Metabolism | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | SVCT1 translocation, SVCT2 translocation |
| NHEK-0119 | Keratinocyte viability & metabolism | Metabolism | Epidermal keratinocytes (NHEK) | Human | SVCT1 translocation, SVCT2 translocation | Microscopy | Basal | |
